Noevir Holdings Co Ltd
TSE:4928
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Noevir Holdings Co Ltd
TSE:4928
|
JP |
|
Microvast Holdings Inc
NASDAQ:MVST
|
US |
|
Gyldendal ASA
OSE:GYL
|
NO |
|
M
|
Makarony Polskie SA
WSE:MAK
|
PL |
|
Treasury Wine Estates Ltd
ASX:TWE
|
AU |
|
Caisse regionale de Credit Agricole Mutuel de Paris et d Ile de France
PAR:CAF
|
FR |
|
Novartis AG
NYSE:NVS
|
CH |
|
M
|
Marinomed Biotech AG
VSE:MARI
|
AT |
|
T2 Biosystems Inc
NASDAQ:TTOO
|
US |
|
S
|
Strauss Group Ltd
TASE:STRS
|
IL |
|
Armor Electric Inc
OTC:ARME
|
US |
|
Plurilock Security Inc
XTSX:PLUR
|
CA |
Wall Street
Price Targets
Price Targets Summary
Noevir Holdings Co Ltd
According to Wall Street analysts, the average 1-year price target for
Noevir Holdings Co Ltd
is 4 865.4 JPY
with a low forecast of 4 817.7 JPY and a high forecast of 5 008.5 JPY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Noevir Holdings Co Ltd's stock price target?
Price Target
4 865.4
JPY
According to Wall Street analysts, the average 1-year price target for
Noevir Holdings Co Ltd
is 4 865.4 JPY
with a low forecast of 4 817.7 JPY and a high forecast of 5 008.5 JPY.
What is Noevir Holdings Co Ltd's Revenue forecast?
Projected CAGR
2%
For the last 13 years the
compound annual growth rate for
Noevir Holdings Co Ltd's revenue is
2%.
The projected
CAGR
for the next 3 years is
2%.
What is Noevir Holdings Co Ltd's Net Income forecast?
Projected CAGR
2%
For the last 13 years the
compound annual growth rate for
Noevir Holdings Co Ltd's net income is
8%.
The projected
CAGR
for the next 3 years is
2%.
